… Perros P, Colley S, Boelaert K, Evans C, Evans RM, Gerrard GE, Gilbert JA, Harrison B,
Johnson SJ, Giles TE, Moss L, Lewington V, Newbold KL, Taylor J, Thakker RV, Watkinson J …

… 0.5% of ZES patients will have all normal values. If a BAO is performed, 1 85% of patients
without previous gastric acid-reducing surgery will have a value 1 15 mEq/h [26] . …

Systemic therapy using bone-seeking radiopharmaceuticals has clear advantages for the
treatment of multisite metastatic pain. Evidence supporting the use of β-particle, electron, and α…

Nuclear medicine plays an increasingly important role in the management neuroendocrine
neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission tomography/…

Dik J. Kwekkeboom a Eric P. Krenning a Klemens Scheidhauer b Val Lewington c Rachida
Lebtahi d Ashley Grossman e Pavel Vitek f Anders Sundin g Ursula Plöckinger h and the …

Neuroblastoma is an enigmatic disease entity; some tumors disappear spontaneously
without any therapy, while others progress with a fatal outcome despite the implementation of …

The palliative efficacy of strontium-89 chloride has been evaluated in a prospective double-blind
crossover study comparing it with stable strontium as placebo in 32 patients with …

Background A qualitative assessment of conventional bone scintigraphy with 99m Tc
methylene diphosphonate is perceived as an insensitive method for monitoring the treatment …

Importance Targeted alpha therapy attempts to deliver systemic radiation selectively to cancer
cells while minimizing systemic toxic effects and may lead to additional treatment options …

The aim of this single-site, open-label clinical trial was to determine the biodistribution,
pharmacokinetics, absorbed doses, and safety from 2 sequential weight-based administrations of …